502 related articles for article (PubMed ID: 27275383)
1. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
Cancer Metab; 2016; 4():11. PubMed ID: 27275383
[TBL] [Abstract][Full Text] [Related]
2. Heat-stabilised rice bran consumption by colorectal cancer survivors modulates stool metabolite profiles and metabolic networks: a randomised controlled trial.
Brown DG; Borresen EC; Brown RJ; Ryan EP
Br J Nutr; 2017 May; 117(9):1244-1256. PubMed ID: 28643618
[TBL] [Abstract][Full Text] [Related]
3.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
4. Navy Beans Impact the Stool Metabolome and Metabolic Pathways for Colon Health in Cancer Survivors.
Baxter BA; Oppel RC; Ryan EP
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30583518
[TBL] [Abstract][Full Text] [Related]
5. Metabolite profile comparisons between ascending and descending colon tissue in healthy adults.
Baxter BA; Parker KD; Nosler MJ; Rao S; Craig R; Seiler C; Ryan EP
World J Gastroenterol; 2020 Jan; 26(3):335-352. PubMed ID: 31988593
[TBL] [Abstract][Full Text] [Related]
6. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults.
Weir TL; Manter DK; Sheflin AM; Barnett BA; Heuberger AL; Ryan EP
PLoS One; 2013; 8(8):e70803. PubMed ID: 23940645
[TBL] [Abstract][Full Text] [Related]
7. Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer.
Fan X; Rao J; Zhang Z; Li D; Cui W; Zhang J; Wang H; Tou F; Zheng Z; Shen Q
Cell Physiol Biochem; 2018; 46(4):1317-1330. PubMed ID: 29689551
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiling analysis for clinical urine of colorectal cancer.
Ning W; Qiao N; Zhang X; Pei D; Wang W
Asia Pac J Clin Oncol; 2021 Aug; 17(4):403-413. PubMed ID: 34164923
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
[TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
12. A gas chromatography-mass spectrometry (GC-MS) metabolomic approach in human colorectal cancer (CRC): the emerging role of monosaccharides and amino acids.
Barberini L; Restivo A; Noto A; Deidda S; Fattuoni C; Fanos V; Saba L; Zorcolo L; Mussap M
Ann Transl Med; 2019 Dec; 7(23):727. PubMed ID: 32042743
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features.
Long Z; Zhou J; Xie K; Wu Z; Yin H; Daria V; Tian J; Zhang N; Li L; Zhao Y; Wang F; Wang M; Cui Y
Front Oncol; 2020; 10():981. PubMed ID: 32626659
[No Abstract] [Full Text] [Related]
14. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
[TBL] [Abstract][Full Text] [Related]
15. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
[TBL] [Abstract][Full Text] [Related]
16. Characterizing metabolic changes in human colorectal cancer.
Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
[TBL] [Abstract][Full Text] [Related]
17. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
[TBL] [Abstract][Full Text] [Related]
18. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis.
Williams MD; Zhang X; Belton AS; Xian L; Huso T; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
J Proteome Res; 2015 Mar; 14(3):1420-31. PubMed ID: 25643065
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
